We are live on
!
Find out more
ANI Pharmaceuticals
ANIP
ANIP
201 hedge funds and large institutions have $962M invested in ANI Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 74 increasing their positions, 62 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
459% more call options, than puts
Call options by funds: $3.16M | Put options by funds: $566K
19% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 62
10% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 30
5.12% more ownership
Funds ownership: 66.98% → 72.1% (+5.1%)
1% more funds holding
Funds holding: 200 → 201 (+1)
1% less capital invested
Capital invested by funds: $975M → $962M (-$12.9M)
Holders
201
Holders Change
+1
Holders Change %
+0.5%
% of All Funds
2.9%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
33
Increased
74
Reduced
62
Closed
30
Calls
$3.16M
Puts
$566K
Net Calls
+$2.6M
Net Calls Change
+$38.4M
Top Buyers
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$19.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$16.2M |
| 3 |
Millennium Management
New York
|
+$13.6M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$11.3M |
| 5 |
GACM
Global Alpha Capital Management
Montreal,
Quebec, Canada
|
+$8.84M |
